JOHN M. LEONARD Insider Trading $ABBV AbbVie Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN M. LEONARD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN M. LEONARD. JOHN M. LEONARD is Director in CHIMERIX INC ($CMRX) and Director in Vitae Pharmaceuticals, Inc ($VTAE) and Director in Quintiles Transnational Holdings Inc. ($Q) and SVP, Chief Scientific Officer in AbbVie Inc. ($ABBV) and CEO in Intellia Therapeutics, Inc. ($NTLA) and EVP, R&D in Intellia Therapeutics, Inc. ($NTLA) and President and CEO in Intellia Therapeutics, Inc. ($NTLA).
JOHN M. LEONARD in AbbVie Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN M. LEONARD: SVP, Chief Scientific Officer
Holdings: 107,320 shares
Current Value: $6,508,958
Latest Transaction: Mar 19 2013
$ABBV Market Capitalization: $98.42B
$ABBV Previous Close: $60.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN M. LEONARD in AbbVie Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABBV, CMRX, NTLA, IQV, VTAE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Option Exercise | M | 28.86 | 46,700 | 1,347,893 | 46,700 | |
| Mar 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Sell | S | 38.45 | 46,700 | 1,795,615 | 107,320 | 154 K to 107.3 K (-30.32 %) |
| Mar 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Buy | M | 28.86 | 46,700 | 1,347,893 | 154,020 | 107.3 K to 154 K (+43.51 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Sell | S | 37.50 | 23,644 | 886,650 | 107,320 | 131 K to 107.3 K (-18.05 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Sell | S | 37.58 | 4,305 | 161,782 | 130,964 | 135.3 K to 131 K (-3.18 %) |
| Mar 04 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Payment of Exercise | F | 36.73 | 9,407 | 345,519 | 135,269 | 144.7 K to 135.3 K (-6.50 %) |
| Feb 21 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Option Exercise | M | 27.29 | 29,650 | 809,267 | 29,650 | |
| Feb 21 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Payment of Exercise | F | 37.58 | 25,345 | 952,465 | 148,981 | 174.3 K to 149 K (-14.54 %) |
| Feb 21 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Buy | M | 27.29 | 29,650 | 809,267 | 174,326 | 144.7 K to 174.3 K (+20.49 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Option Exercise | A | 35.88 | 62,020 | 2,225,278 | 62,020 | |
| Feb 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Payment of Exercise | F | 37.58 | 7,982 | 299,964 | 144,676 | 152.7 K to 144.7 K (-5.23 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Grant | A | 0.00 | 30,360 | 0 | 152,658 | 122.3 K to 152.7 K (+24.82 %) |
Page: 1